Morgan Stanley’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-514
| Closed | -$2K | – | 6916 |
|
|
2017
Q4 | $2K | Buy |
+514
| New | +$2K | ﹤0.01% | 6472 |
|
|
2017
Q3 | – | Sell |
-2,660
| Closed | -$19K | – | 6828 |
|
|
2017
Q2 | $19K | Buy |
2,660
+1,773
| +200% | +$12.7K | ﹤0.01% | 6109 |
|
|
2017
Q1 | $8K | Sell |
887
-1,677
| -65% | -$15.1K | ﹤0.01% | 6288 |
|
|
2016
Q4 | $251K | Sell |
2,564
-1,272
| -33% | -$125K | ﹤0.01% | 5263 |
|
|
2016
Q3 | $381K | Buy |
3,836
+3,137
| +449% | +$312K | ﹤0.01% | 4686 |
|
|
2016
Q2 | $85K | Buy |
699
+144
| +26% | +$17.5K | ﹤0.01% | 5316 |
|
|
2016
Q1 | $71K | Buy |
+555
| New | +$71K | ﹤0.01% | 5473 |
|
|
2015
Q2 | – | Sell |
-41
| Closed | -$7K | – | 7029 |
|
|
2015
Q1 | $7K | Hold |
41
| – | – | ﹤0.01% | 6302 |
|
|
2014
Q4 | $8K | Buy |
41
+2
| +5% | +$390 | ﹤0.01% | 6262 |
|
|
2014
Q3 | $8K | Sell |
39
-5
| -11% | -$1.03K | ﹤0.01% | 6259 |
|
|
2014
Q2 | $7K | Sell |
44
-1,782
| -98% | -$284K | ﹤0.01% | 6260 |
|
|
2014
Q1 | $365K | Buy |
+1,826
| New | +$365K | ﹤0.01% | 4768 |
|